Premature Ovarian Insufficiency Linked to Autoimmune Diseases
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 1, 2024 -- Women diagnosed with premature ovarian insufficiency (POI) have an increased prevalence of severe autoimmune diseases, according to a study published online Sept. 25 in Human Reproduction.
Susanna M. Savukoski, M.D., from Oulu University Hospital in Finland, and colleagues conducted a population-based registry study of 3,972 women diagnosed with spontaneous POI between 1988 and 2017 and 15,708 female population controls to examine the association with severe autoimmune diseases before and after POI diagnosis.
The researchers found that the prevalence of having at least one severe autoimmune disease was 5.6 percent in women with POI. Compared with controls, women with POI had an increased prevalence of several specific autoimmune diseases prior to the index date including polyglandular autoimmune diseases, Addison disease, vasculitis, systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis, inflammatory bowel diseases, and hyperthyroidism. No difference was seen in the prevalence of type 1 diabetes or ankylosing spondylitis. During the first three years after POI diagnosis, the standardized incidence ratio for being diagnosed for the first time with a severe autoimmune disease was 2.8, which decreased to 1.3 after 12 years.
"The study results strengthen the hypothesis that autoimmune mechanisms play an important role in the pathogenesis of POI," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Depressive Symptoms Common for Women With Premature Ovarian Insufficiency
TUESDAY, July 22, 2025 -- The prevalence of depressive symptoms is high among women with premature ovarian insufficiency (POI), according to a study published online July 16...
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss...
Many Indicators of Anger Expression Decrease With Age in Women
THURSDAY, July 10, 2025 -- Aging is significantly related to anger in women, with most indicators of anger expression decreasing with age, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.